Sleep apnea therapy linked to lower risk for diabetes

An investigator at McGill University in Montreal says there's evidence to suggest that sleep apnea therapy can reduce the risk of developing diabetes. In a small study involving 39 overweight middle-aged people considered at risk for developing diabetes, the group being treated for sleep apnea demonstrated lower levels of the stress hormone norepinephrine as well as lower blood pressure than the placebo arm. "Our study showed that CPAP in patients with prediabetes can lower their risk of progressing to diabetes when CPAP is used for eight hours, a full night's sleep," concluded the study's lead author, Sushmita Pamidi. Release

Suggested Articles

Dutch scientists used stem cells from CF patients to demonstrate a technique that corrects a mutation in the gene CFTR without having to cut DNA.

A new map of the thymus gland could help researchers understand how T cells develop and inspire treatments for cancer and autoimmune disease.

Brigham and Women’s Hospital scientists linked a noncoding RNA to atherosclerosis in a discovery that could aid in the development of new heart drugs.